National Institutes of Health U.S. Department of Health and Human Services
The Cancer Genome Atlas (TCGA) is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing. TCGA is a joint effort of the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), which are both part of the National Institutes of Health, U.S. Department of Health and Human Services.
Mission and Goal
The Cancer Genome Atlas will assess the feasibility of a full-scale effort to systematically explore the entire spectrum of genomic changes involved in human cancer.
The overarching goal of The Cancer Genome Atlas is to improve our ability to diagnose, treat and prevent cancer.
Mapping the Cancer Genome
In the March 2007 issue of Scientific American, NHGRI Director Francis S. Collins and National Cancer Institute Deputy Director for Advanced Technologies and Strategic Partnerships Anna D. Barker find that pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies.
Toward a Comprehensive Genomic Analysis of Cancer [cancergenome.nih.gov]
The report from a workshop co-organized by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) as part of their collaboration to initiate the pilot phase of the Human Cancer Genome Project (HCGP), July 20-22, 2005.